0001628280-23-029142.txt : 20230811 0001628280-23-029142.hdr.sgml : 20230811 20230811184640 ACCESSION NUMBER: 0001628280-23-029142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woo Liyuan CENTRAL INDEX KEY: 0001499747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39565 FILM NUMBER: 231165624 MAIL ADDRESS: STREET 1: 400 VALLEY DRIVE CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beauty Health Co CENTRAL INDEX KEY: 0001818093 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 851908962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2165 SPRING STREET CITY: LONG BEACH STATE: CA ZIP: 90806 BUSINESS PHONE: 800-603-4996 MAIL ADDRESS: STREET 1: 2165 SPRING STREET CITY: LONG BEACH STATE: CA ZIP: 90806 FORMER COMPANY: FORMER CONFORMED NAME: Vesper Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20200714 4 1 wk-form4_1691793990.xml FORM 4 X0508 4 2023-08-10 1 0001818093 Beauty Health Co SKIN 0001499747 Woo Liyuan C/O THE BEAUTY HEALTH COMPANY 2165 SPRING STREET LONG BEACH CA 90806 0 0 0 1 Former Chief Financial Officer 0 Stock Options (right to buy) 12.85 2023-08-10 4 D 0 372000 D 2031-05-06 Common Stock 372000 0 D Stock Options (right to buy) 12.85 2023-08-10 4 A 0 372000 A 2025-08-10 Common Stock 372000 372000 D The transaction involves an amendment of an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the "Plan"). As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the "Separation Date"), 372,000 shares underlying the option, had vested (the "Vested Options") and the other 372,000 shares underlying the option, had not vested (the "Unvested Options"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date. However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025. /s/ Paul Bokota, Attorney-in-Fact for Liyuan Woo 2023-08-11